Unicorn Nest

Unicorn Nest

CAGE Bio Announces $7.2M Series A Round

18 Feb, 2021

CAGE Bio Announces $7.2M Series A Round

– CAGE Bio from San Carlos is an innovative biotechnology company focused on developing innovative therapies for infection, inflammation and immunology.
– The company announced the closing of a $7.2m Series A financing.

Biotechnology Health Care Medical North America

Related Posts

Rohlik Raises €190M in Funding

Rohlik Raises €190M in Funding

03 Mar, 2021
Morris Homes Announces Investment from Atlantic Park to Support Next Phase of Growth

Morris Homes Announces Investment from Atlantic Park to Support Next Phase of Growth

03 Mar, 2021
Retail Zipline raises $30M as it helps retailers adapt to the pandemic

Retail Zipline raises $30M as it helps retailers adapt to the pandemic

03 Mar, 2021
Xendit Raises US$64.6 Million Series B Led by Accel to Scale Its Digital Payments Infrastructure Ushering in a New Era of Economic Security and Reliability in Southeast Asia

Xendit Raises US$64.6 Million Series B Led by Accel to Scale Its Digital Payments Infrastructure Ushering in a New Era of Economic Security and Reliability in Southeast Asia

03 Mar, 2021

Crunchbase icon

Find your perfect investor now

Content report

The following text will be sent to our editors:

Send